SEK 31 million to enhance the effect of immunotherapy in the treatment of cancer patients
Göran Jönsson, professor of molecular oncology, receives SEK 31 million from the Knut and Alice Wallenberg Foundation to enhance the effect of immunotherapy in the treatment of cancer patients. About 30 per cent of patients with metastatic melanoma benefit from immunotherapy. At the same time, this means that 70 per cent of all melanoma patients still have no effective treatment option. Göran Jöns
https://www.lucc.lu.se/article/sek-31-million-enhance-effect-immunotherapy-treatment-cancer-patients - 2025-11-07
